Purpose. Antifungal resistance and several putative virulence factors have been associated with the pathogenicity of the Candida parapsilosis species complex. The objective of this study was to evaluate the antifungal susceptibility, the production of virulence factors and the pathogenicity of the C. parapsilosis complex.
Methodology. Overall, 49 isolates of C. parapsilosis sensu stricto, 19 C. orthopsilosis and nine C. metapsilosis were used. The planktonic and biofilm susceptibility to fluconazole, itraconazole, voriconazole, amphotericin B and caspofungin was assessed using a broth microdilution assay. Finally, the production of biofilm and hydrolytic enzymes and the fungal pathogenicity against Caenorhabditis elegans were investigated.
Results/Key findings. Overall, one C. orthopsilosis was resistant to caspofungin and susceptible-dose-dependent to itraconazole, the other two C. orthopsilosis were susceptible-dose-dependent to fluconazole and itraconazole, and one C. metapsilosis was susceptible-dose-dependent to azoles. A total of 67.5 % of the isolates were biofilm producers. Amphotericin B and caspofungin caused the greatest reduction in the metabolic activity and biomass of mature biofilms. Phospholipase and protease production was observed in 55.1 % of C. parapsilosis sensu stricto, 42.1 % of C. orthopsilosis and 33.3 % of C. metapsilosis isolates. Moreover, 57.9 % of C. orthopsilosis and 20.4 % of C. parapsilosis sensu stricto isolates were β-haemolytic, and all C. metapsilosis were α-haemolytic. Finally, the C. parapsilosis complex caused high mortality of C. elegans after 96 h of exposure.
Conclusion. These results reinforce the heterogeneity of these cryptic species for their antifungal susceptibility, virulence and pathogenic potential, emphasizing the relevance of monitoring these emerging pathogens.
BrilhanteRS,
de AlencarLP,
CordeiroRA,
Castelo-BrancoDS,
TeixeiraCE et al. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health. J Med Microbiol2013; 62:889–895 [View Article][PubMed]
BrilhanteRS,
OliveiraJS,
EvangelistaAJJ,
SerpaR,
SilvaADL et al.Candida tropicalis from veterinary and human sources shows similar in vitro haemolytic activity, antifungal biofilms susceptibility and pathogenesis against Caenohabditis elegans
. Vet Microbiol2016; 30:213–219[Crossref]
FalagasME,
RoussosN,
VardakasKZ.
Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis2010; 14:e954-66 [View Article][PubMed]
MenezesR,
FerreiraJC,
de SáWM,
MoreiraT,
MalvinoLDS et al. Frequency of Candida species in a tertiary care hospital in Triangulo Mineiro, Minas Gerais State, Brazil. Ver Inst Med Trop S Paulo2015; 57:185–191 [View Article]
BarchiesiF,
OrsettiE,
OsimaniP,
CatassiC,
SantelliF et al. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex. BMC Infect Dis2016; 16:387–394 [View Article][PubMed]
GonçalvesSS,
AmorimCS,
NucciM,
PadovanAC,
BrionesMR et al. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect2010; 16:885–887 [View Article][PubMed]
CantónE,
PemánJ,
QuindósG,
ErasoE,
Miranda-ZapicoI et al. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother2011; 55:5590–5596 [View Article][PubMed]
TothR,
TothA,
VagvolgyiC,
GacserA.
Candida parapsilosis secreted lipase as an important virulence factor. Curr Protein Pept Sci2017; 18:1043–1049 [View Article][PubMed]
TavantiA,
DavidsonAD,
GowNA,
MaidenMC,
OddsFC.
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol2005; 43:284–292 [View Article][PubMed]
van AsbeckEC,
ClemonsKV,
StevensDA.
Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit Rev Microbiol2009; 35:283–309 [View Article][PubMed]
BrilhanteRS,
de Jesus Santos RodriguesT,
de Souza Collares Maia Castelo-BrancoD,
TeixeiraCE,
de Brito MacedoR et al. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J Med Microbiol2014; 63:1568–1572 [View Article][PubMed]
da SilvaBV,
SilvaLB,
de OliveiraDB,
da SilvaPR,
Ferreira-PaimK et al. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates recovered from clinical specimens. Mycopathologia2015; 180:333–343 [View Article][PubMed]
ZiccardiM,
SouzaLO,
GandraRM,
GaldinoAC,
BaptistaAR et al.Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes. Int J Med Microbiol2015; 305:848–859 [View Article][PubMed]
CordeiroRA,
de OliveiraJS,
Castelo-BrancoDS,
TeixeiraCE,
MarquesFJ et al.Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factors. Med Mycol2015; 53:145–152 [View Article][PubMed]
BrilhanteRS,
PaivaMA,
SampaioCM,
TeixeiraCE,
Castelo-BrancoDS et al. Yeasts from Macrobrachium amazonicum: a focus on antifungal susceptibility and virulence factors of Candida spp. FEMS Microbiol Ecol2011; 76:268–277 [View Article][PubMed]
AtaidesFS,
CostaCR,
SouzaLK,
FernandesO,
JesuinoRS et al. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples. Rev Soc Bras Med Trop2015; 48:454–459 [View Article][PubMed]
MorenoX,
ReviakinaV,
PanizoMM,
FerraraG,
GarcíaN et al. Molecular identification and in vitro antifungal susceptibility of blood isolates of the Candida parapsilosis species complex in Venezuela. Rev Iberoam Micol2017; 34:165–170 [View Article][PubMed]
RuizLS,
KhouriS,
HahnRC,
da SilvaEG,
de OliveiraVK et al. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility. Mycopathologia2013; 175:231–239 [View Article][PubMed]
KuhnDM,
ChandraJ,
MukherjeePK,
GhannoumMA.
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun2002; 70:878–888 [View Article][PubMed]
LattifAA,
MukherjeePK,
ChandraJ,
SwindellK,
LockhartSR et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis
. Int J Med Microbiol2010; 300:265–270 [View Article][PubMed]
PannanusornS,
Ramírez-ZavalaB,
LünsdorfH,
AgerberthB,
MorschhäuserJ et al. Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis
. Eukaryot Cell2014; 13:438–451 [View Article][PubMed]
Treviño-RangelRJ,
GonzálezJG,
GonzálezGM.
Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex. Med Mycol2013; 51:331–335 [View Article][PubMed]
NémethT,
TóthA,
SzenzensteinJ,
HorváthP,
NosanchukJD et al. Characterization of virulence properties in the C. parapsilosis sensu lato species. PLoS One2013; 8:e68704 [View Article][PubMed]